Latest Breaking News On - Institut paoli calmettes - Page 1 : vimarsana.com

Innate Pharma Reports First Quarter 2024 Business Update and Financial Results

Innate Pharma SA: Innate Pharma Reports First Quarter 2024 Business Update and Financial Results

France: Medical robotics company Quantum Surgical gets EIB loan to advance tumour treatment

Peripheral Blood Haplo-SCT Feasible for Leukemia Patients 70 Years and Older

WEDNESDAY, Dec. 20, 2023 (HealthDay News) -- For patients with acute myeloid leukemia (AML)/myelodysplastic syndromes (MDS) aged 70 years and older, haploidentical stem cell transplantation (Haplo-SCT) using a nonmyeloablative conditioning regimen (NMAC) is feasible, with no early nonrelapse mortality (NRM), according to a study published online Nov. 3 in Bone Marrow Transplantation. Samia Harbi, M.D.,

Peripheral blood haplo-SCT feasible for leukemia patients 70 years and older

Innate Pharma SA: Innate Pharma Reports Third Quarter 2023 Financial Results and Business Update

Innate Pharma Reports Third Quarter 2023 Financial Results and Business Update

ImCheck Presented Updated Positive Data from Phase I/IIa EVICTION-2 Trial of ICT01 in Combination with Low-dose IL-2 at SITC 2023

ImCheck Presented Updated Positive Data from Phase I/IIa EVICTION-2 Trial of ICT01 in Combination with Low-dose IL-2 at SITC 2023Interim data from...

ImCheck Presented Updated Positive Data from Phase I/IIa

ImCheck Presented Updated Positive Data from Phase I/IIa EVICTION-2 Trial of ICT01 in Combination with Low-dose IL-2 at SITC 2023 Interim data from...

ImCheck Presented Updated Positive Data from Phase I/IIa EVICTION-2 Trial of ICT01 in Combination with Low-dose IL-2 at SITC 2023